Is Medicaid Expansion Associated with Improved Nonmetastatic Colon Cancer Survival? An Analysis of the National Cancer Database
- PMID: 35213813
- PMCID: PMC9402807
- DOI: 10.1177/00031348211050816
Is Medicaid Expansion Associated with Improved Nonmetastatic Colon Cancer Survival? An Analysis of the National Cancer Database
Abstract
Methods: This retrospective study of 86 413 patients (40-64 years old) undergoing surgical resection for a new diagnosis of invasive, nonmetastatic colon cancer included in the National Cancer Database (NCDB) from 2010 to 2015 compared overall survival (OS) in MES to NES. Cox proportional hazard models, fit for OS, and propensity score-matching (PSM) analysis were performed.
Results: In this sample, 51 297 cases (59.2%) lived in MES and 35 116 (40.8%) in NES. Medicaid expansion states had earlier pathological stage compared to NES (stage I 25.38% vs 24.17%, stage II 32.93 vs 33.4%, and stage III 41.69 vs 42.43%; P < .001). 5-year OS in MES was higher than NES (79.1% vs 77.3%; P < .001); however, on both multivariable analysis (MVA) and PSM analysis, MES did not have significantly different OS from NES (hazard ratio (HR), .99, 95% confidence interval (CI), .95-1.03; P = .570; HR, .99, 95% CI, .95-1.03; P = .68).
Conclusion: Among NCDB patients with invasive, nonmetastatic colon cancer residing in MES at time of diagnosis was associated with earlier pathological stage. However, on both MVA and PSM analysis, OS was not significantly different in MES vs NES. Research on patient outcomes, such as receipt of guideline concordant care, can further inform the impact of insurance coverage expansion efforts on cancer outcomes.
Keywords: colorectal; socioeconomic.
Conflict of interest statement
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures



Similar articles
-
Association of time to resection with survival in patients with colon cancer.Surg Endosc. 2024 Feb;38(2):614-623. doi: 10.1007/s00464-023-10548-2. Epub 2023 Nov 27. Surg Endosc. 2024. PMID: 38012438
-
Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients.Cureus. 2021 Jun 18;13(6):e15748. doi: 10.7759/cureus.15748. eCollection 2021 Jun. Cureus. 2021. PMID: 34285854 Free PMC article.
-
Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.Cancer Med. 2019 Oct;8(14):6295-6304. doi: 10.1002/cam4.2441. Epub 2019 Sep 4. Cancer Med. 2019. PMID: 31483578 Free PMC article.
-
Medicaid Expansion and Mortality Among Patients With Breast, Lung, and Colorectal Cancer.JAMA Netw Open. 2020 Nov 2;3(11):e2024366. doi: 10.1001/jamanetworkopen.2020.24366. JAMA Netw Open. 2020. PMID: 33151317 Free PMC article.
-
Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.J Surg Res. 2020 Jan;245:265-272. doi: 10.1016/j.jss.2019.07.059. Epub 2019 Aug 14. J Surg Res. 2020. PMID: 31421372
Cited by
-
Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured.Cancer Med. 2024 Jul;13(13):e7461. doi: 10.1002/cam4.7461. Cancer Med. 2024. PMID: 38970338 Free PMC article.
-
Closing the Gap: Approaches to Improving Colorectal Surgery Care for the Uninsured and Underinsured.Clin Colon Rectal Surg. 2024 May 15;38(1):49-57. doi: 10.1055/s-0044-1786398. eCollection 2025 Jan. Clin Colon Rectal Surg. 2024. PMID: 39734719 Free PMC article. Review.
-
Effect of Chemotherapy Treatment on Overall Survival of Colon Cancer Patients Using Propensity Score Matching.Cureus. 2025 May 11;17(5):e83892. doi: 10.7759/cureus.83892. eCollection 2025 May. Cureus. 2025. PMID: 40497185 Free PMC article.
-
Association of Medicaid expansion with colon cancer care: treatment patterns and survival in non-metastatic cases from state registry-claims data.Cancer Causes Control. 2025 Jun 23. doi: 10.1007/s10552-025-01983-8. Online ahead of print. Cancer Causes Control. 2025. PMID: 40549121
References
-
- Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW. An assessment of progress in cancer control. CA Cancer J Clin. 2018;68(5):329–339. - PubMed
-
- Sauer AG, Siegel RL, Jemal A, Fedewa SA. Updated review of prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomark Prev. 2017;26(8):1192–1208. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2019;66(1):7–30. - PubMed
-
- Ahmed A, Tahseen A, England E, et al. Association between primary payer status and survival in patients with stage iii colon cancer: an national cancer database analysis. Clin Colorectal Canc. 2019;18(1):e1–e7. - PubMed
-
- Finegold KCA, Chu RC, Bosworth A, Sommers BD. Trends in the U.S. Uninsured Population, 2010-2020. In: Services. USDoHaH. Washington, DC: Office of the Assistant Secretary for Planning and Evaluation; 2021.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous